Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Pharmaniaga Berhad
Pharmaniaga Berhad News
No news available
Pharmaniaga Berhad Quantitative Score
About Pharmaniaga Berhad
Pharmaniaga Berhad, an investment holding company, operates as an integrated pharmaceutical company in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products. The company also manufactures and sells generic drugs; over-the-counter medicines; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and operates community pharmacies under the RoyalePharma brand name. The company was founded in 1994 and is based in Shah Alam, Malaysia. Pharmaniaga Berhad is a subsidiary of Boustead Holdings Berhad.
Pharmaniaga Berhad Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Pharmaniaga Berhad Financials
Table Compare
Compare 7081.KL metrics with: | |||
|---|---|---|---|
Earnings & Growth | 7081.KL | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | 7081.KL | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | 7081.KL | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | 7081.KL | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Pharmaniaga Berhad Income
Pharmaniaga Berhad Balance Sheet
Pharmaniaga Berhad Cash Flow
Pharmaniaga Berhad Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Buy |
| Return on Assets | Neutral |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Neutral |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Pharmaniaga Berhad Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 0.0410 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2023-01-06 | 0.00356696 | Quarterly |
| 2022-10-04 | 0.00297246 | Quarterly |
| 2022-07-06 | 0.00475594 | Quarterly |
| 2022-04-05 | 0.02972465 | Quarterly |
| 2021-12-29 | 0.01188986 | Quarterly |
Historical Market Cap
Shares Outstanding
Pharmaniaga Berhad Executives
| Name | Role |
|---|---|
| Zulkifli Bin Jafar | Deputy Chief Executive Officer, Managing Director & Director |
| Ahmad Shahredzuan Bin Mohd Shariff | Chief Operating Officer |
| Badarulhisam Abdul Rahman | Chief Scientific Officer |
| Ahmad Abu Bakar | Head of Indonesia Operations |
| Hayat Al-Mazli Yahaya | Acting Head of Human Capital Management & Administration |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Zulkifli Bin Jafar | Deputy Chief Executive Officer, Managing Director & Director | Male | 1972 | 1.31M |
| Ahmad Shahredzuan Bin Mohd Shariff | Chief Operating Officer | Male | 1983 | 127.5K |
| Badarulhisam Abdul Rahman | Chief Scientific Officer | 1968 | -- | |
| Ahmad Abu Bakar | Head of Indonesia Operations | Male | 1969 | -- |
| Hayat Al-Mazli Yahaya | Acting Head of Human Capital Management & Administration | Male | -- |